Biotech Investments Remain Necessary To Speed Future R&D - Pfizer Exec
Executive Summary
The increasing complexity of modern drug discovery will require large pharmaceutical firms to continue to partner with biotechnology companies, Pfizer Exec VP Hank McKinnell, PhD, told the Biotechnology Industry Organization CEO & Investors Conference in New York City Feb. 24.